• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[核因子κB对非酒精性脂肪性肝病致病进程的影响]

[Effect of NF-κB on the pathogenic course of non-alcoholic fatty liver disease].

作者信息

Wu Li, Xie Yutao

机构信息

Department of Infectious Disease, Xiangya Hospital, Central South University, Changsha 410008, China.

出版信息

Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2017 Apr 28;42(4):463-467. doi: 10.11817/j.issn.1672-7347.2017.04.016.

DOI:10.11817/j.issn.1672-7347.2017.04.016
PMID:28490707
Abstract

With the economic growth and better standards of living, the prevalence of non-alcoholic fatty liver disease (NAFLD) is expected to increase dramatically worldwide. NAFLD is a common chronic inflammation disease. NF-κB is a transcription factor that plays crucial roles in inflammation, immunity, cell proliferation and apoptosis. It can facilitate the occurrence and development of NAFLD, and the underlying mechanisms are related to insulin resistance, oxidative stress, alteration of intestinal flora, activation of renin angiotensin system, etc.

摘要

随着经济增长和生活水平提高,预计非酒精性脂肪性肝病(NAFLD)在全球的患病率将急剧上升。NAFLD是一种常见的慢性炎症性疾病。核因子κB(NF-κB)是一种转录因子,在炎症、免疫、细胞增殖和凋亡中起关键作用。它可促进NAFLD的发生和发展,其潜在机制与胰岛素抵抗、氧化应激、肠道菌群改变、肾素血管紧张素系统激活等有关。

相似文献

1
[Effect of NF-κB on the pathogenic course of non-alcoholic fatty liver disease].[核因子κB对非酒精性脂肪性肝病致病进程的影响]
Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2017 Apr 28;42(4):463-467. doi: 10.11817/j.issn.1672-7347.2017.04.016.
2
Resveratrol modulates autophagy and NF-κB activity in a murine model for treating non-alcoholic fatty liver disease.白藜芦醇在治疗非酒精性脂肪肝病的小鼠模型中调节自噬和 NF-κB 活性。
Food Chem Toxicol. 2014 Jan;63:166-73. doi: 10.1016/j.fct.2013.08.036. Epub 2013 Aug 24.
3
Role of oxidative stress and insulin resistance in disease severity of non-alcoholic fatty liver disease.氧化应激和胰岛素抵抗在非酒精性脂肪性肝病疾病严重程度中的作用。
Turk J Gastroenterol. 2016 Jul;27(4):361-6. doi: 10.5152/tjg.2016.16106.
4
Effect of nuclear factor-κB and angiotensin II receptor type 1 on the pathogenesis of rat non-alcoholic fatty liver disease.核因子-κB及1型血管紧张素II受体在大鼠非酒精性脂肪性肝病发病机制中的作用
World J Gastroenterol. 2015 May 21;21(19):5877-83. doi: 10.3748/wjg.v21.i19.5877.
5
Preventing non-alcoholic fatty liver disease through Lactobacillus johnsonii BS15 by attenuating inflammation and mitochondrial injury and improving gut environment in obese mice.通过减轻肥胖小鼠的炎症和线粒体损伤以及改善肠道环境,使用约翰逊乳杆菌 BS15 预防非酒精性脂肪肝疾病。
Appl Microbiol Biotechnol. 2014 Aug;98(15):6817-29. doi: 10.1007/s00253-014-5752-1. Epub 2014 May 9.
6
Dysregulation of autophagy acts as a pathogenic mechanism of non-alcoholic fatty liver disease (NAFLD) induced by common environmental pollutants.自噬失调是常见环境污染物诱导的非酒精性脂肪性肝病(NAFLD)的致病机制。
Ecotoxicol Environ Saf. 2021 Jul 1;217:112256. doi: 10.1016/j.ecoenv.2021.112256. Epub 2021 Apr 23.
7
Endoplasmic reticulum stress and Oxidative stress in the pathogenesis of Non-alcoholic fatty liver disease.内质网应激与氧化应激在非酒精性脂肪性肝病发病机制中的作用
Free Radic Res. 2015;49(12):1405-18. doi: 10.3109/10715762.2015.1078461. Epub 2015 Aug 25.
8
Gut Microbiota as a Driver of Inflammation in Nonalcoholic Fatty Liver Disease.肠道微生物群作为非酒精性脂肪性肝病炎症的驱动因素。
Mediators Inflamm. 2018 Jan 31;2018:9321643. doi: 10.1155/2018/9321643. eCollection 2018.
9
Gut Microbiota: Association with NAFLD and Metabolic Disturbances.肠道微生物群:与非酒精性脂肪性肝病及代谢紊乱的关联
Biomed Res Int. 2015;2015:979515. doi: 10.1155/2015/979515. Epub 2015 May 19.
10
Non-alcoholic fatty liver disease and dyslipidemia: An update.非酒精性脂肪性肝病与血脂异常:最新进展
Metabolism. 2016 Aug;65(8):1109-23. doi: 10.1016/j.metabol.2016.05.003. Epub 2016 May 13.

引用本文的文献

1
Hepatocellular carcinoma: pathogenesis, molecular mechanisms, and treatment advances.肝细胞癌:发病机制、分子机制及治疗进展
Front Oncol. 2025 Apr 8;15:1526206. doi: 10.3389/fonc.2025.1526206. eCollection 2025.
2
Obesity, non-alcoholic fatty liver disease and hepatocellular carcinoma: current status and therapeutic targets.肥胖、非酒精性脂肪性肝病和肝细胞癌:现状和治疗靶点。
Front Endocrinol (Lausanne). 2023 Jun 8;14:1148934. doi: 10.3389/fendo.2023.1148934. eCollection 2023.
3
Dietary Flaxseed Oil Prevents Western-Type Diet-Induced Nonalcoholic Fatty Liver Disease in Apolipoprotein-E Knockout Mice.
饮食亚麻籽油可预防载脂蛋白 E 基因敲除小鼠的西式饮食诱导的非酒精性脂肪肝疾病。
Oxid Med Cell Longev. 2017;2017:3256241. doi: 10.1155/2017/3256241. Epub 2017 Sep 7.